Numeric Investors’s Impax Laboratories, Inc. IPXL Stock Holding History

Numeric Investors’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-18,000	Closed	-$453K	–	962
2013 Q4	$453K	Sell	18,000 -900	-5%	-$20.1K	0.01%	621
2013 Q3	$387K	Sell	18,900 -3,500	-16%	-$72.3K	0.01%	627
2013 Q2	$447K	Buy	+22,400	New	+$398K	0.01%	556

Other funds holding IPXL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Numeric Investors's IPXL Position: Q1 2014 in Review

Numeric Investors sold out of Impax Laboratories, Inc. (IPXL) in Q1 2014, closing a stake of 18,000 shares — an estimated $453K sold.

Numeric Investors first reported a position in IPXL in Q2 2013 and held it in 3 quarters. The position peaked at $453K in Q4 2013. 181 funds tracked by Wall St. Rank hold IPXL as of Q1 2014.

Numeric Investors reported no remaining Impax Laboratories, Inc. position as of Q1 2014 after selling out during the quarter.
Numeric Investors sold 18,000 Impax Laboratories, Inc. shares in Q1 2014, an estimated $453K.
Numeric Investors first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 3 quarters.
Numeric Investors's Impax Laboratories, Inc. position peaked at $453K in Q4 2013.
181 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2014.

Based on Numeric Investors's 13F filing for Q1 2014, filed 6 May 2014.